The repertoire of human antibodies to the carbohydrate capsule of Streptococcus pneumoniae 6B

Journal of Infectious Diseases

Volumn 174, Issue 1, 1996, Pages 75-82

  Park, Moon K ^b   Sun, Yan ^c   Olander, Jitka V ^c   Hoffmann, Joseph W ^c   Nahm, Moon H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Chonbuk National University   (South Korea)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CARBOHYDRATE; CROSS REACTING ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; PNEUMOCOCCUS VACCINE;

ADULT; AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ANTIBODY STRUCTURE; ANTIGEN BINDING; ARTICLE; BACTERIAL MEMBRANE; HUMAN; HUMAN EXPERIMENT; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; NORMAL HUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0030035878     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.1.75     Document Type: Article

References (13)

1. Fedson DS. Pneumococcal vaccine. In: Plotkin SA, Mortimer A Jr, eds. Vaccines. Orlando, FL: WB Saunders, 1988:271-99.
2. Robbins JB, Austrian R, Lee CJ, et al. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 1983; 148:1136-59.
3. Siber GR. Pneumococcal disease: prospects for a new generation of vaccines. Science 1994;265:1385-7.
4. Shapiro ED, Austrian R. Serotypes responsible for invasive Streptococcus pneumoniae infections among children in Connecticut. J Infect Dis 1994;169:212-4.
5. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.
6. Viooarsson G, Jónsdóttir I, Jónsson S, Valdimarsson H. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae. J Infect Dis 1994;170:592-9.
7. Bortolussi R, Marrie TJ, Cunningham J, Schiffman G. Serum antibody and opsonic responses after immunization with pneumococcal vaccine in kidney transplant recipients and controls. Infect Immun 1981;34: 20-5.
8. Romero-Steiner S, Pais L, Holder P, Carlone GM, Keyserling HL. Opsonophagocytosis of Streptococcus pneumoniae as an indicator of functional antibody activity in adults vaccinated with a 23-valent polysaccharide vaccine [abstract E042]. In: Proceedings of the annual meeting of the American Society for Microbiology (Washington, DC). Washington, DC: ASM, 1995.
9. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 1993;270:1826-31.
10. Musher DM, Luchi MJ, Watson DA, Hamilton R, Baughn RE. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis 1990;161:728-35.
11. Siber GR, Priehs C, Madore DV. Standardization of antibody assays for measuring the response to pneumococcal infection and immunization. Pediatr Infect Dis J 1989;8:584-91.
12. Jefferis R, Reimer CB, Skvaril F, et al. Evaluation of monoclonal antibodies having specificity for human IgG subclasses: results of an IUIS/ WHO collaborative study. Immunol Lett 1985;10:223-52.
13. Tarrand JJ, Scott MG, Takes PA, Nahm MH. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. Demonstration of three types of V regions and their association with H and L chain isotypes. J Immunol 1989;142: 2519-26.